Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-02

Clinical Trial Update: A Study to Investigate the Relative Bioavailability and Food Effect of an Oral Capsid Inhibitor Tablet Formulation Compared With Other Oral Tablet Formulations in Male and Female Healthy Participants [Phase 1]

View source ↗

Summary

This Phase 1 trial compares the relative bioavailability and food effect of an oral capsid inhibitor tablet formulation against other tablet formulations in hea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SUNLENCA (LENACAPAVIR SODIUM)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: COMPLETED